Protease-sparing regimen

Protease-sparing regimen often abbreviated as PSR, is a method or therapy for treating people infected with HIV that involves a three-drug combination that reduces viral load below the limit of detection while saving protease inhibitors for later use. It is considered a weaker (in terms of quantity and concentration) form of HIV treatment. It has been argued that such a regimen is not as potent as giving HIV patients with the strongest drugs as soon as it is detected. Others believe that this might be considered a long-term strategy in order to reduce the amount of HIV, and in some instances have proven to be successful

See also

• Protease
• Women's Interagency HIV Study

References

• http://www.projinf.org/pip/26/pip26i.html
• http://www.projinf.org/pip/25/pip25a.html
• http://www.aegis.com/conferences/iac/2000/WePeB4134.html
• http://www.aids-ed.org/aidsetc?page=et-14-00-02
• http://www.medscape.com/viewarticle/418668